⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KLRA News
Kailera Therapeutics, Inc. Common Stock
Federal Peptide Policy Shift Could Ignite a New Wave Of Growth Across the $164 Billion Peptide Market
globenewswire.com
MBX
ALT
HIMS
KLRA
Form 8-K
sec.gov
KLRA
Kailera Reports Third Quarter 2026 Financial Results and Provides Business Updates
globenewswire.com
KLRA
Kailera Therapeutics to Participate in November Investor Conferences
globenewswire.com
KLRA
Kailera Therapeutics Presents New Clinical Data at EASD 2026 Annual Meeting
globenewswire.com
KLRA
Kailera Therapeutics Announces Completion of Enrollment in KaiNETIC Global Phase 3 Clinical Program of GLP-1/GIP Receptor Dual Agonist Ribupatide Injection
globenewswire.com
KLRA
Kailera Therapeutics to Participate in September Investor Conferences
globenewswire.com
KLRA
Form 8-K
sec.gov
KLRA
Kailera Reports Second Quarter 2026 Financial Results and Provides Business Updates
globenewswire.com
KLRA
Kailera Therapeutics Appoints Nur Nicholson as Chief Technology Officer
globenewswire.com
KLRA